Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2022 ∙ Toubasi, A. A. Al-Sayegh, T. N. Obaid, Y. Y. Al-Harasis, S. M. AlRyalat, S. A. S.
Efficacy and safety of COVID-19 vaccines: A network meta-analysis
Adolescents Adults COVID-19 Safety Efficacy/effectiveness
Rating:
Low
2022 ∙ Graña, C. Ghosn, L. Evrenoglou, T. Jarde, A. Minozzi, S. Bergman, H. Buckley, B. S. Probyn, K. Villanueva, G. Henschke, N. et al.,
Efficacy and safety of COVID‐19 vaccines
Children Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Moderate
2022 ∙ Efros, O. Anteby, R. Halfon, M. Meisel, E. Klang, E. Soffer, S.
Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2022 ∙ Rinaldi, I. Pratama, S. Wiyono, L. Tandaju, J. R. Wardhana, I. L. Winston, K.
Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis
Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Diallo, A. Carlos-Bolumbu, M. Diallo, M. H. Makinson, A. Galtier, F.
Efficacy of approved vaccines to prevent COVID-19: a systematic review and network meta-analysis of reconstructed individual patient data from randomized trials
Adolescents Adults Older adults Healthcare workers COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2022 ∙ Perez Navarro, A. Pilkington, V. Pepperrell, T. Mirchandani, M. Levi, J. Hill, A.
Efficacy of Approved Versus Unapproved Vaccines for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Randomized Blinded Clinical Trials
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2022 ∙ Salari, N. Vepa, A. Daneshkhah, A. Darvishi, N. Ghasemi, H. Khunti, K. Mohammadi, M.
Efficacy of COVID-19 vaccines by race and ethnicity
All age groups COVID-19 Efficacy/effectiveness Ethical issues Safety
Rating:
Critically low
2022 ∙ Lee, A. R. Y. B. Wong, S. Y. Chai, L. Y. A. Lee, S. C. Lee, M. X. Muthiah, M. D. Tay, S. H. Teo, C. B. Tan, B. K. J. Chan, Y. H. Sundar, R. Soon, Y. Y.
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
2022 ∙ Kumar, S. Saikia, D. Bankar, M. Saurabh, M. K. Singh, H. Varikasuvu, S. R. Maharshi, V.
Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Li, Z. Liu, S. Li, F. Li, Y. Li, Y. Peng, P. Li, S. He, L. Liu, T.
Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
Loading...